Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHAMAB-B

6.150
-0.150-2.38%
Volume:3.65M
Turnover:22.37M
Market Cap:5.92B
PE:32.50
High:6.300
Open:6.300
Low:6.010
Close:6.300
Loading ...

Company Profile

Company Name:
ALPHAMAB-B
Exchange:
SEHK
Establishment Date:
2008
Employees:
420
Office Location:
No. 175 Fangzhou Road,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Zip Code:
215127
Fax:
- -
Introduction:
Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.

Directors

Name
Position
XU Ting
Chairman of the Board,Executive Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee
LIU Yang
Executive Director,Chairman of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee
Wei Cheng, Kevin
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman
WU Dong
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
GUO Zi Jian
Independent Director,Member of the Strategic and Development Committee,Member of the Nomination Committee,Audit Committee Member
ZUO Min
Director

Shareholders

Name
Position
XU Ting
CEO
CHEN Luo Er
Corporate Secretary
CHENG Jia Lan
Corporate Secretary
LIU Yang
Other Senior Executives